• About the Society
  • SPIE Altruism
  • International Year of Light
  • Fellows and Senior Members
  • Awards Programs
  • Press Room
  • Press Releases
    SPIE Member News
    Event News
    Press Kits and Fact Sheets
    PR Contacts
    RSS Collection
    Social Media
    SPIE Logos and Name
    Press Registration
  • Public Policy
  • Related Organizations
  • Jobs at SPIE
Print PageEmail Page

Jena team receives Thuringian Award for Applied Research

13 February 2013

Juergen Popp Andreas Tuennermann
Jürgen Popp Andreas

SPIE Fellows Jürgen Popp of the Institute of Physical Chemistry, FSU, and  the Institute of Photonic Technology (IPHT)  and Andreas Tünnermann  of the Institute of Applied Physics, FSU, and  Fraunhofer Institute for Applied Optics and Precision Engineering (IOF) are among a team of Jena-based scientists who were presented with the Thuringian Research Award for Applied Research by the Ministry for Education, Science and Culture of Thuringia on 8 February.

The researchers from the IPHT, the Institute of Physical Chemistry (IPC), the Institute of Applied Physics (IAP), IOF, and Jena University Hospital were recognized for their investigations into a multi-contrast imaging approach that will serve as a key to powerful clinical diagnostics.

This award has been given since 1995 for outstanding research and knowledge transfer achievements in the categories "Basic Research," "Applied Research" and "Transfer" and is endowed with 50,000 euros.

The Jena team's research contributes to the objective of improving clinical diagnostics, one of the central domains of modern health care. With an increasing average age of the population, the requirements for medical care are also growing. The risk of cardiovascular diseases and cancer both increase with age. Novel approaches in diagnostics and therapy are necessary to guarantee optimal care in the future and limit costs. This can best be achieved with an early and accurate diagnosis of disease, because time plays a key role in successful treatment.

Despite the availability of modern imaging methods such as magnetic resonance tomography, computed tomography, and ultrasound, it is not possible today to examine the chemical composition of patient samples or image structures smaller than a single cell without destroying them or marking them with dyes.

The efficiency of this new technique was particularly demonstrated for diseases such as arteriosclerosis and larynx or colon cancer. The new method has been created by the scientists from Jena in such way that it can be integrated in clinical practice without high costs or extensive training for the medical staff.

In developing the award-winning technology, physicists, engineers and physicians worked closely together on the medical requirements and technological means to develop an optimal system. The result was a combination of microscope and laser source, which is predestined for the clinical use, as the method enables non-specialist personnel to carry out multi-contrast imaging outside of laser laboratories in excellent quality.

Along with Popp and Tünnermann, team members are Benjamin Dietzek (IPC and Institute of Photonic Technology), Jens Limpert (IAP and IOF), and Andreas Stallmach, Orlando Guntinas-Lichius, and Bernd Romeike (Jena University Hospital).